Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort - Ta-Wei Liu, Pei-Chien Tsai, Ching-I. Huang, Yi-Shan Tsai, Shu-Chi Wang, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Nai-Jen Hou, Chung-Feng Huang, Ming-Lun Yeh, Zu-Yau Lin - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Elsevier, Journal of the Formosan Medical Association, 1(117), p. 54-62, 2018

DOI: 10.1016/j.jfma.2017.02.013

Links

Tools

Export citation

Search in Google Scholar

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort

Journal article published in 2018 by Ta-Wei Liu, Pei-Chien Tsai, Ching-I. Huang, Yi-Shan Tsai, Shu-Chi Wang, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Nai-Jen Hou, Chung-Feng Huang, Ming-Lun Yeh, Zu-Yau Lin and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Green circle

Published version: archiving allowed

Upload

Policy details

Data provided by

SHERPA/RoMEO